Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Efficacy of nurse-led and general practitioner-led comprehensive geriatric assessment in primary care: protocol of a pragmatic three-arm cluster randomised controlled trial (CEpiA study).

Ferrat E, Bastuji-Garin S, Paillaud E, Caillet P, Clerc P, Moscova L, Gouja A, Renard V, Attali C, Breton JL, Audureau E.

BMJ Open. 2018 Apr 12;8(4):e020597. doi: 10.1136/bmjopen-2017-020597.

2.

Restructuration des soins ambulatoires en France : propositions de gestion des patients hypertendus.

Clerc P, Duhot D, Breton JL.

Sante Publique. 2015 Mar-Apr;1 Suppl:209-17. French. No abstract available.

PMID:
26414274
3.

Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial.

Quoix E, Ramlau R, Westeel V, Papai Z, Madroszyk A, Riviere A, Koralewski P, Breton JL, Stoelben E, Braun D, Debieuvre D, Lena H, Buyse M, Chenard MP, Acres B, Lacoste G, Bastien B, Tavernaro A, Bizouarne N, Bonnefoy JY, Limacher JM.

Lancet Oncol. 2011 Nov;12(12):1125-33. doi: 10.1016/S1470-2045(11)70259-5. Epub 2011 Oct 21.

PMID:
22019520
4.

[Management and outcome of French elderly patients with lung cancer: an IFCT survey].

Quoix E, Monnet I, Scheid P, Hamadouche A, Chouaid C, Massard G, Depierre A, Souquet PJ, Braun D, Girard P, Breton JL, Lebitasy MP, Milleron B; l'Intergroupe francophone de cancérologie thoracique (IFCT).

Rev Mal Respir. 2010 May;27(5):421-30. doi: 10.1016/j.rmr.2010.02.013. Epub 2010 Mar 25. French.

PMID:
20569874
5.

[Iris metastasis of bronchial carcinoma: a case report].

Subiger L, Breton JL, Poulin G.

J Fr Ophtalmol. 2008 May;31(5):527-32. French.

6.

[Management of non-small cell lung carcinoma following docetaxel-cisplatin. Results of an epidemiologic survey].

Breton JL, Robinet G, Dansin E, Rotarski M, Le Groumellec A, Dourthe LM, Hamid A, Ecstein-Fraisse E.

Rev Mal Respir. 2007 Nov;24(9):1099-106. French.

PMID:
18176386
7.

Rurality and survival differences in lung cancer: a large population-based multivariate analysis.

Pozet A, Westeel V, Berion P, Danzon A, Debieuvre D, Breton JL, Monnier A, Lahourcade J, Dalphin JC, Mercier M.

Lung Cancer. 2008 Mar;59(3):291-300. Epub 2007 Oct 22.

PMID:
17933419
8.

Phase III double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy: an intergroup study FNCLCC cleo04 IFCT 00-01.

Pujol JL, Breton JL, Gervais R, Tanguy ML, Quoix E, David P, Janicot H, Westeel V, Gameroff S, Genève J, Maraninchi D.

J Clin Oncol. 2007 Sep 1;25(25):3945-51.

PMID:
17761978
9.

Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).

Blanchon T, Bréchot JM, Grenier PA, Ferretti GR, Lemarié E, Milleron B, Chagué D, Laurent F, Martinet Y, Beigelman-Aubry C, Blanchon F, Revel MP, Friard S, Rémy-Jardin M, Vasile M, Santelmo N, Lecalier A, Lefébure P, Moro-Sibilot D, Breton JL, Carette MF, Brambilla C, Fournel F, Kieffer A, Frija G, Flahault A; Dépiscan Group.

Lung Cancer. 2007 Oct;58(1):50-8. Epub 2007 Jul 12.

PMID:
17624475
10.

Phase II clinical trial of the epothilone B analog, ixabepilone, in patients with non small-cell lung cancer whose tumors have failed first-line platinum-based chemotherapy.

Vansteenkiste J, Lara PN Jr, Le Chevalier T, Breton JL, Bonomi P, Sandler AB, Socinski MA, Delbaldo C, McHenry B, Lebwohl D, Peck R, Edelman MJ.

J Clin Oncol. 2007 Aug 10;25(23):3448-55. Epub 2007 Jul 2. Erratum in: J Clin Oncol. 2007 Nov 20;25(33):5339. Edelman, Mark [corrected to Edelman, Martin J].

PMID:
17606973
11.

[IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer].

Westeel V, Lebitasy MP, Mercier M, Girard P, Barlesi F, Blanchon F, Tredaniel J, Bonnette P, Woronoff-Lemsi MC, Breton JL, Azarian R, Falcoz PE, Friard S, Geriniere L, Laporte S, Lemarie E, Quoix E, Zalcman G, Guigay J, Morin F, Milleron B, Depierre A; Intergroupe Francophone de Cancerologie Thoracique (IFCT).

Rev Mal Respir. 2007 May;24(5):645-52. French.

PMID:
17519819
12.

Weekly paclitaxel combined with monthly carboplatin in elderly patients with advanced non-small cell lung cancer: a multicenter phase II study.

Pujol JL, Milleron B, Molinier O, Quoix E, Depierre A, Breton JL, Gervais R, Debieuvre D, Hominal S, Namouni F, Tonelli D.

J Thorac Oncol. 2006 May;1(4):328-34.

13.

Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: a GLOT-GFPC study.

Cortot AB, Gerinière L, Robinet G, Breton JL, Corre R, Falchero L, Berard H, Gimenez C, Chavaillon JM, Perol M, Bombaron P, Mercier C, Souquet PJ; Groupe Lyon-Saint-Etienne d'Oncologie Thoracique; Groupe Français de Pneumo-Cancérologie.

Ann Oncol. 2006 Sep;17(9):1412-7. Epub 2006 Jun 21.

PMID:
16790516
14.

Vinflunine -- an active chemotherapy for treatment of advanced non-small-cell lung cancer previously treated with a platinum-based regimen: results of a phase II study.

Bennouna J, Breton JL, Tourani JM, Ottensmeier C, O'Brien M, Kosmidis P, Huat TE, Pinel MC, Colin C, Douillard JY.

Br J Cancer. 2006 May 22;94(10):1383-8.

15.

Long-duration, weekly treatment with gemcitabine plus vinorelbine for non-small cell lung cancer: a multicenter phase II study.

Westeel V, Breton JL, Braun D, Quoix E, Milleron B, Debieuvre D, Jacoulet P, Germa C, Kayitalire L, Depierre A.

Lung Cancer. 2006 Mar;51(3):347-55. Epub 2006 Feb 15.

PMID:
16469410
16.

A randomised phase II study of the efficacy and safety of intravenous topotecan in combination with either cisplatin or etoposide in patients with untreated extensive disease small-cell lung cancer.

Quoix E, Breton JL, Gervais R, Wilson J, Schramel F, Cardenal F, Ross G, Preston A, Lymboura M, Mattson K.

Lung Cancer. 2005 Aug;49(2):253-61.

PMID:
16022920
17.

Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer.

Westeel V, Quoix E, Moro-Sibilot D, Mercier M, Breton JL, Debieuvre D, Richard P, Haller MA, Milleron B, Herman D, Level MC, Lebas FX, Puyraveau M, Depierre A; French Thoracic Oncology Collaborative Group (GCOT).

J Natl Cancer Inst. 2005 Apr 6;97(7):499-506.

PMID:
15812075
18.

[Primary lung cancer in elderly subjects in France].

Piquet J, Blanchon F, Grivaux M, Collon T, Zureik M, Barbieux H, Bénichou-Flurin M, Breton JL, Coëtmeur D, Delclaux B, Braun D, Homasson JP, Mouysset F, Riou R, le Poulain-Doubliez M, Marsal L; CPHG.

Rev Mal Respir. 2004 Nov;21(5 Pt 3):8S70-8. French.

PMID:
15803540
19.

Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin.

Pujol JL, Breton JL, Gervais R, Rebattu P, Depierre A, Morère JF, Milleron B, Debieuvre D, Castéra D, Souquet PJ, Moro-Sibilot D, Lemarié E, Kessler R, Janicot H, Braun D, Spaeth D, Quantin X, Clary C.

Ann Oncol. 2005 Apr;16(4):602-10. Epub 2005 Mar 1.

PMID:
15741225
20.

First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week schedule.

Quoix E, Breton JL, Ducoloné A, Mennecier B, Depierre A, Lemarié E, Moro-Sibilot D, Germa C, Neidhardt AC.

Lung Cancer. 2005 Mar;47(3):405-12.

PMID:
15713524
21.

Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC).

Gervais R, Ducolone A, Breton JL, Braun D, Lebeau B, Vaylet F, Debieuvre D, Pujol JL, Tredaniel J, Clouet P, Quoix E.

Ann Oncol. 2005 Jan;16(1):90-6.

PMID:
15598944
22.

[Do combinations without cisplatin represent an alternative to conventional chemotherapy in non-small cell lung cancers?].

Pujol JL, Jacot W, Breton JL, Gervais R, Quantin X, Rebattu P.

Rev Pneumol Clin. 2004 Nov;60(5 Pt 2):3S60-7. Review. French.

PMID:
15536356
23.

Lung cancer among women in France. Analysis of the 904 French women with lung cancer included in the KBP-2000-CPHG study of the French College of General Hospital-based Pneumologists (CPHG).

Grivaux M, Breton JL, Bombaron P, Kuntz P, Lebas FX, Mehdaoui A, Herman D, David P, Berruchon J, Delclaux B, Zureik M, Blanchon F; French College of General Hospital-based Pneumologists.

Lung Cancer. 2004 Sep;45(3):279-87.

PMID:
15301868
24.

[Treatment of non-small cell lung cancer (2003 update)].

Lavolé A, Blanchon F, Breton JL, Milleron B.

Rev Mal Respir. 2004 Feb;21(1):175-8. Review. French. No abstract available.

PMID:
15260057
25.

[Lung cancer among French women in 2000: results of an epidemiological study (KBP-2000)].

Blanchon F, Grivaux M, Breton JL.

Rev Pneumol Clin. 2003 Nov;59(5 Pt 2):S56-8. French. No abstract available.

PMID:
14707919
26.

Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy for non-small-cell lung cancer.

Quoix E, Lebeau B, Depierre A, Ducolone A, Moro-Sibilot D, Milleron B, Breton JL, Lemarie E, Pujol JL, Brechot JM, Zalcman G, Debieuvre D, Vaylet F, Vergnenegre A, Clouet P.

Ann Oncol. 2004 Jan;15(1):38-44.

PMID:
14679117
27.

[Primary bronchial carcinoma in elderly subjects in France].

Piquet J, Blanchon F, Grivaux M, Collon T, Zureik M, Barbieux H, Bénichou-Flurin M, Breton JL, Coëtmeur D, Delclaux B, Braun D, Homasson JP, Mouysset F, Riou R, le Poulain-Doubliez M, Marsal L; CPHG.

Rev Mal Respir. 2003 Nov;20(5 Pt 1):691-9. French.

PMID:
14631248
28.

Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000).

Depierre A, Lagrange JL, Theobald S, Astoul P, Baldeyrou P, Bardet E, Bazelly B, Bréchot JM, Breton JL, Douillard JY, Grivaux M, Jacoulet P, Khalil A, Lemarié E, Martinet Y, Massard G, Milleron B, Molina T, Moro-Sibilot D, Paesmans M, Pujol JL, Quoix E, Ranfaing E, Rivière A, Sancho-Garnier H, Souquet PJ, Spaeth D, Stoebner-Delbarre A, Thiberville L, Touboul E, Vaylet F, Vergnon JM, Westeel V; FNCLCC.

Br J Cancer. 2003 Aug;89 Suppl 1:S35-49. No abstract available.

29.

[Standards, Options and Recommendations for the management of non-small cell lung carcinoma patients].

Depierre A, Lagrange JL, Theobald S, Astoul P, Baldeyrou P, Bardet E, Bazelly B, Bréchot JM, Breton JL, Douillard JY, Grivaux M, Jacoulet P, Khalil A, Lemarié E, Martinet Y, Massard G, Milleron B, Molina T, Moro-Sibilot D, Paesmans M, Pujol JL, Quoix E, Ranfaing E, Rivière A, Sancho-Garnier H, Souquet JP, Spaeth D, Stoebner-Delbarre A, Thiberville L, Touboul E, Vaylet F, Vergnon JM, Westeel V.

Bull Cancer. 2003 Feb;90(2):151-66. French.

30.

[Epidemiologic of primary bronchial carcinoma management in the general French hospital centers].

Blanchon F, Grivaux M, Collon T, Zureik M, Barbieux H, Bénichou-Flurin M, Breton JL, Coëtmeur D, Delclaux B, Asselain B, Piquet J.

Rev Mal Respir. 2002 Dec;19(6):727-34. French.

PMID:
12524492
31.

[2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer].

Bréchot JM, Molina T, Theobald S, Depierre A, Lagrange JL, Astoul P, Baldeyrou P, Bardet E, Bazelly B, Breton JL, Douillard JY, Grivaux M, Jacoulet P, Khalil A, Lemarié E, Martinet Y, Massard G, Milleron B, Moro-Sibilot D, Paesmans M, Pujol JL, Quoix AE, Ranfaing E, Rivière A, Sancho-Garnier H, Souquet PJ, Spaeth D, Stcebner-Delbarre A; FNCLCC, CRLCC.

Bull Cancer. 2002 Oct;89(10):857-67. French.

32.

Oral vinorelbine: feasibility and safety profile.

Depierre A, Freyer G, Jassem J, Orfeuvre H, Ramlau R, Lemarie E, Koralewski P, Mauriac L, Breton JL, Delozier T, Trillet-Lenoir V.

Ann Oncol. 2001 Dec;12(12):1677-81.

PMID:
11843244
33.

Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer.

Depierre A, Milleron B, Moro-Sibilot D, Chevret S, Quoix E, Lebeau B, Braun D, Breton JL, Lemarié E, Gouva S, Paillot N, Bréchot JM, Janicot H, Lebas FX, Terrioux P, Clavier J, Foucher P, Monchâtre M, Coëtmeur D, Level MC, Leclerc P, Blanchon F, Rodier JM, Thiberville L, Villeneuve A, Westeel V, Chastang C; French Thoracic Cooperative Group.

J Clin Oncol. 2002 Jan 1;20(1):247-53.

PMID:
11773176
34.

Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: a phase II study.

Quoix E, Breton JL, Daniel C, Jacoulet P, Debieuvre D, Paillot N, Kessler R, Moreau L, Coëtmeur D, Lemarié E, Milleron B.

Ann Oncol. 2001 Jul;12(7):957-62.

PMID:
11521802
35.

[Standards, Options and Recommendations for the management of stage I or II primary bronchial cancers treated exclusively with radiotherapy].

Touboul E, Lagrange JL, Theobald S, Astoul P, Baldeyrou P, Bardet E, Bazelly B, Bréchot J, Breton JL, Douillard JY, Grivaux M, Jacoulet P, Khalil A, Le Chevalier T, Lemarie E, Martinet Y, Massard G, Milleron B, Moro-Sibilot D, Paesmans M, Pujol JL, Quoix AE, Ranfaing E, Rivière A, Sancho-Garnier H, Souquet PJ, Spaeth D, Stoebner-Delbarre A, Thiberville L, Vaylet F, Vergnon JM, Westeel V, Depierre A.

Cancer Radiother. 2001 Aug;5(4):452-63. French.

PMID:
11521393
36.

[Standards, options and recommendations for the management of locally advanced non small cell lung carcinoma].

Bardet E, Moro-Sibilot D, Le Chevalier T, Massard G, Douillard JY, Theobald S, Astoul P, Baldeyrou P, Bazelly B, Bréchot J, Breton JL, Grivaux P, Jacoulet P, Khalil A, Lemarie E, Martinet Y, Milleron B, Paesmans M, Pujol JL, Quoix AE, Ranfaing E, Rivière A, Sancho-Garnier H, Souquet PJ, Spaeth D, Stcebner-Delbarre A, Thiberville L, Touboul E, Vaylet F, Vergnon JM, Westeel V, Depierre A, Lagrange JL.

Bull Cancer. 2001 Apr;88(4):369-87. Review. French.

37.

Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1.

Robinet G, Thomas P, Breton JL, Léna H, Gouva S, Dabouis G, Bennouna J, Souquet PJ, Balmes P, Thiberville L, Fournel P, Quoix E, Riou R, Rebattu P, Pérol M, Paillotin D, Mornex F.

Ann Oncol. 2001 Jan;12(1):59-67.

PMID:
11249050
38.

Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study.

Pujol JL, Daurès JP, Rivière A, Quoix E, Westeel V, Quantin X, Breton JL, Lemarié E, Poudenx M, Milleron B, Moro D, Debieuvre D, Le Chevalier T.

J Natl Cancer Inst. 2001 Feb 21;93(4):300-8.

PMID:
11181777
39.

Phase I study of paclitaxel (Taxol) plus vinorelbine (Navelbine) in patients with untreated stage IIIb and IV non-small cell lung cancer.

Breton JL, Westeel V, Jacoulet P, Mercier M, Chazard M, Depierre A.

Lung Cancer. 2001 Feb-Mar;31(2-3):295-301.

PMID:
11165410
40.

[A bulky tumor of the apex].

Alfreijat F, Chague D, Guy I, Breton JL.

Rev Med Interne. 2000 Jun;21(6):555-6. French. No abstract available.

PMID:
10909157
41.

Ferredoxin III of Desulfovibrio africanus: sequencing of the native gene and characterization of a histidine-tagged form.

Busch JL, Breton JL, Davy SL, James R, Moore GR, Armstrong FA, Thomson AJ.

Biochem J. 2000 Mar 1;346 Pt 2:375-84.

42.

[Small-cell bronchogenic cancer one year after excision of 2 synchronous non-small-cell bronchogenic cancers].

Breton JL, Alfreijat F, Guy I.

Rev Pneumol Clin. 1999 Sep;55(4):231-2. French. No abstract available.

PMID:
10573753
43.

[Zopiclone and delirium: a case report].

David M, Breton JL, Guy I, Vandel S.

Therapie. 1998 Jan-Feb;53(1):78-80. French. No abstract available.

PMID:
9773104
44.

Voltammetric studies of the reactions of iron-sulphur clusters ([3Fe-4S] or [M3Fe-4S]) formed in Pyrococcus furiosus ferredoxin.

Fawcett SE, Davis D, Breton JL, Thomson AJ, Armstrong FA.

Biochem J. 1998 Oct 15;335 ( Pt 2):357-68. Erratum in: Biochem J 1998 Dec 15;336(Pt 3):743.

45.

[3Fe-4S] <--> [4Fe-4S] cluster interconversion in Desulfovibrio africanus ferredoxin III: properties of an Asp14 --> Cys mutant.

Busch JL, Breton JL, Bartlett BM, Armstrong FA, James R, Thomson AJ.

Biochem J. 1997 Apr 1;323 ( Pt 1):95-102.

46.

Phase II study of alternating doses of vinorelbine in combination with cisplatin for non-small cell lung cancer (NSCLC): a disappointing experience.

Westeel V, Jacoulet P, Breton JL, Garnier G, Mercier M, Depierre A.

Lung Cancer. 1996 Dec;16(1):61-73.

PMID:
9017585
47.

Expression in Escherichia coli and characterization of a reconstituted recombinant 7Fe ferredoxin from Desulfovibrio africanus.

Busch JL, Breton JL, Bartlett BM, James R, Hatchikian EC, Thomson AJ.

Biochem J. 1996 Feb 15;314 ( Pt 1):63-71.

48.

Identification of the iron-sulfur clusters in a ferredoxin from the archaeon Sulfolobus acidocaldarius. Evidence for a reduced [3Fe-4S] cluster with pH-dependent electronic properties.

Breton JL, Duff JL, Butt JN, Armstrong FA, George SJ, Pétillot Y, Forest E, Schäfer G, Thomson AJ.

Eur J Biochem. 1995 Nov 1;233(3):937-46.

49.

Magnetic circular dichroism study of the selenium-substituted form (Fe3Se4) of bovine heart aconitase.

Breton JL, Farrar JA, Kennedy MC, Beinert H, Thomson AJ.

Biochem J. 1995 Oct 1;311 ( Pt 1):197-202.

50.

Supplemental Content

Loading ...
Support Center